Effect of new method of intracoronary adenosine injection during primary percutaneous coronary intervention on microvascular reperfusion injury - Clinical outcome and 1-year follow-up

Cardiology (Switzerland)

Volumn 124, Issue 3, 2013, Pages 199-206

  Grygier, Marek ^a   Araszkiewicz, Aleksander ^a   Lesiak, Maciej ^a   Grajek, Stefan ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Adenosine; Ischemia; Myocardial infarction; No reflow; Reperfusion

Indexed keywords

ABCIXIMAB; ADENOSINE; PLACEBO;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOGRAPHY; ANGIOPLASTY; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; GUIDING CATHETER; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; INTRACORONARY INFUSION; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; REVASCULARIZATION; ST SEGMENT ELEVATION; TREATMENT OUTCOME; ATRIOVENTRICULAR BLOCK; BALLOON CATHETER; BRADYCARDIA; GUIDE WIRE; HEART ARREST; HEART MUSCLE REVASCULARIZATION; INTRACORONARY DRUG ADMINISTRATION;

ADENOSINE; CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRALESIONAL; MALE; MICROVESSELS; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; PERCUTANEOUS CORONARY INTERVENTION; RECURRENCE; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 84875648410     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000346876     Document Type: Article

References (33)

1. Ito H, Maruyama A, Iwakura K, et al: Clinical implications of 'no-reflow' phenomenon: a predictor of complications and left ventricular remodeling in perfused anterior wall infarction. Circulation 1996; 93: 223-228.
2. Piana RN, Paik GY, Moscucci M, et al: Incidence and treatment of no-reflow after percutaneous coronary intervention. Circulation 1994; 89: 2514-2518.
3. Jaffe R, Charron T, Puley G, et al: Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention. Circulation 2008; 117: 3152-3156.
4. Ndrepepa G, Tiroch K, Fusaro M, et al: 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. J Am Coll Cardiol 2010; 55: 2383-2389.
5. Rezkalla SH, Kloner RA: Coronary no reflow phenomenon: from the experimental laboratory to the cardiac catherization laboratory. Catheter Cardiovasc Interv 2008; 72: 950-957.
6. Klein LW, Kern MJ, Berger P, et al: Society of Cardiac Angiography and Interventions: suggested management of the no-reflow phenomenon in the cardiac catherization laboratory. Catheter Cardiovasc Interv 2003; 60: 194-201.
7. Araszkiewicz A, Grajek S, Lesiak M, et al: Effect of impaired myocardial reperfusion on left ventricular remodelling in patients with anterior wall myocardial infarction treated with primary coronary intervention. Am J Cardiol 2006; 98: 725-728.
8. Steg PG, James SK, Atar D, et al: ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012; 33: 2569-2619.
9. Forman MB, Stone GW, Jackson EK: Role of adenosine as adjunctive therapy in acute myocardial infarction. Cardiovasc Drug Rev 2006; 24: 116-147.
10. Garratt KN, Holmes DR Jr, Molina-Viamonte V, et al: Intravenous adenosine and lidocaine in patients with acute myocardial infarction. Am Heart J 1998; 136: 196-204.
11. Claeys MJ, Bosmans J, De Ceuninck M, et al: Effect of intracoronary adenosine infusion during coronary intervention on myocardial reperfusion injury in patients with acute myocardial infarction. Am J Cardiol 2004; 94: 9-13.
12. Marzilli M, Orsini E, Marraccini P, Testa R: Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction. Circulation 2000; 101: 2154-2159.
13. Mahaffey KW, Puma JA, Barbagelata NA, et al: Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebocontrolled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial. J Am Coll Cardiol 1999; 34: 1711-1720.
14. Ross AM, Gibbons RJ, Stone GW, Kloner RA, Alexander RW, AMISTAD-II Investigators: A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment acute myocardial infarction (AMISTAD-2). J Am Coll Cardiol 2005; 45: 1775-1780.
15. Kloner RA, Forman MB, Gibbons RJ, Ross AM, Alexander RW, Stone GW: Impact of time to therapy and reperfusion modality on the efficacy of adenosine in acute myocardial infarction: the AMISTAD-2 trial. Eur Heart J 2006; 27: 2400-2405.
16. Quintana M, Hjemdahl P, Sollevi A, et al: Left ventricular function and cardiovascular events following adjuvant therapy with adenosine in acute myocardial infarction treated with thrombolysis, results of the ATTenuation by Adenosine of Cardiac Complications (ATTACC) study. Eur J Clin Pharmacol 2003; 59: 1-9.
17. Fokkema ML, Vlaar P, Vogelzang M, et al: Effect of high-dose intracoronary adenosine administration during percutaneous coronary intervention in acute myocardial infarction - a randomized controlled trial. Circ Cardiovasc Intervent 2009; 2: 323-329.
18. Stoel MG, Marques KM, de Cock CC, Bronzwaer JG, von Birgelen C, Zijlstra F: High-dose adenosine for suboptimal myocardial reperfusion after primary PCI: a randomized placebo- controlled pilot study. Catheter Cardiovasc Interv 2008; 71: 283-289.
19. Assali AR, Sdringola S, Ghani M, et al: Intracoronary adenosine administered during percutaneous intervention in acute myocardial infarction and reduction in the incidence of no-reflow phenomenon. Catheter Cardiovasc Interv 2000; 51: 27-31.
20. Grygier M, Araszkiewicz A, Lesiak M, et al: New method of intracoronary adenosine injection to prevent of microvascular reperfusion injury in patients with acute myocardial infarction undergoing percutaneous coronary intervention. Am J Cardiol 2011; 107: 1131-1135.
21. Gibson CM, Cannon CP, Daley WL, et al: TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 1996; 93: 879-888.
22. van't Hof AW, Liem A, Suryapranata H, Hoorntje JC, de Boer MJ, Zijlstra F: Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial infarction Study Group. Circulation 1998; 97: 2302-2306.
23. van't Hof AW, Liem A, de Boer MJ, Zijlstra F: Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Zwolle Myocardial infarction Study Group. Lancet 1997; 350: 615-619.
24. Brodie BR, Stuckey TD, Hansen C, et al: Relation between electrocardiographic ST-segment resolution and early and late outcomes after primary percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol 2005; 95: 343-348.
25. Forman MB, Jackson EK: Importance of tissue perfusion in ST segment elevation myocardial infarction patients undergoing reperfusion strategies: role of adenosine. Clin Cardiol 2007; 30: 583-585.
26. Brosh D, Asali AR, Mayer A, et al: Effect of no-reflow during primary percutaneous intervention for acute myocardial infarction on six-month mortality. Am J Cardiol 2007; 99: 442-445.
27. Desemet W, Bogaert J, Dubois C, et al: Highdose intracoronary adenosine for myocardial salvage in patients with acute ST-segment elevation myocardial infarction. Eur Heart J 2011; 32: 867-877.
28. Aletras AH, Tilak GS, Natanzon A, et al: Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2- weighted cardiac magnetic resonance imaging: histopatological and displacement encoding with stimulated echoes (DENSE) functional validations. Circulation 2006; 113: 1865-1870.
29. Carlsson M, Ubachs JFA, Hedstrom E, et al: Myocardium at risk after acute infarction in humans on cardiac magnetic resonance: quantitative assessment during follow-up and val i dation with single-photon emission computed tomography. J Am Coll Cardiol 2009; 2: 569-576.
30. Marzilli M, Klasen GA, Marraccini P, et al: Coronary effect of adenosine in conscious man. Eur Heart J 1989; 10 (suppl 7):78-81.
31. Sakuma T, Motoda C, Tokuyama T, et al: Exogenous adenosine triphosphate disodium administration during primary percutaneous coronary intervention reduces no-reflow and preserves left ventricular function in patients with acute anterior myocardial infarction: a study using myocardial contrast echocardiography. Int J Cardiol 2010; 140: 200-209.
32. Wang J, Chen Y, Zhi G, et al: Beneficial effect of adenosine on myocardial perfusion treated with primary percutaneous coronary intervention for acute myocardial infarction. Clin Exp Pharmacol Physiol 2012; 39: 247-252.
33. Navarese EP, Buffon A, Andreotti F, et al: Adenosine improves post-procedural coronary flow but not clinical outcomes in patients with acute coronary syndrome: a meta-analysis of randomized trials. Atherosclerosis 2012; 222: 1-7.